https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2005-08-01 / Clin. Cancer Res. 2005 Aug;11(15):5515-25
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2005-08-01 / Clin. Cancer Res. 2005 Aug;11(15):5515-252005-08-01 00:00:002019-02-15 08:46:55Dendritic cell vaccination in glioblastoma patients induces systemic and intracranial T-cell responses modulated by the local central nervous system tumor microenvironment
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2005-08-01 / Int. J. Oncol. 2005 Aug;27(2):377-84
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2005-08-01 / Int. J. Oncol. 2005 Aug;27(2):377-842005-08-01 00:00:002020-06-23 09:37:35Tumor-targeted gene transfer in vivo via recombinant Newcastle disease virus modified by a bispecific fusion protein
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2005-08-01 / Br. J. Haematol. 2005 Aug;130(3):344-62
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2005-08-01 / Br. J. Haematol. 2005 Aug;130(3):344-622005-08-01 00:00:002019-02-15 09:25:43Immunotherapy in multiple myeloma–possibility or probability?
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2005-07-26 / Cancer Immunol. Immunother. 2006 Mar;55(3):299-311
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2005-07-26 / Cancer Immunol. Immunother. 2006 Mar;55(3):299-3112005-07-26 00:00:002019-02-15 09:17:46Dynamic control of lymphocyte trafficking by fever-range thermal stress
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2005-07-21 / Cancer Immunol. Immunother. 2006 Mar;55(3):268-76
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2005-07-21 / Cancer Immunol. Immunother. 2006 Mar;55(3):268-762005-07-21 00:00:002019-02-15 08:39:00Induction of cellular immune responses against carcinoembryonic antigen in patients with metastatic tumors after vaccination with altered peptide ligand-loaded dendritic cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2005-07-15 / Cancer Immunol. Immunother. 2006 Apr;55(4):420-32
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2005-07-15 / Cancer Immunol. Immunother. 2006 Apr;55(4):420-322005-07-15 00:00:002019-02-15 09:25:37Adjuvant IL-15 does not enhance the efficacy of tumor cell lysate-pulsed dendritic cell vaccines for active immunotherapy of T cell lymphoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2005-07-15 / J. Immunol. 2005 Jul;175(2):820-8
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2005-07-15 / J. Immunol. 2005 Jul;175(2):820-82005-07-15 00:00:002019-02-15 08:38:55Dendritic cell-mediated cross-presentation of antigens derived from colon carcinoma cells exposed to a highly cytotoxic multidrug regimen with gemcitabine, oxaliplatin, 5-fluorouracil, and leucovorin, elicits a powerful human antigen-specific CTL response with antitumor activity in vitro
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2005-07-07 / Oncology 2005;68(2-3):276-84
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2005-07-07 / Oncology 2005;68(2-3):276-842005-07-07 00:00:002019-02-15 08:38:53Dendritic cells and vascular endothelial growth factor in colorectal cancer: correlations with clinicobiological findings
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2005-07-01 / Hum. Immunol. 2005 Jul;66(7):762-72
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2005-07-01 / Hum. Immunol. 2005 Jul;66(7):762-722005-07-01 00:00:002019-02-15 08:35:30Human papillomavirus L1L2-E7 virus-like particles partially mature human dendritic cells and elicit E7-specific T-helper responses from patients with cervical intraepithelial neoplasia or cervical cancer in vitro
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2005-07-01 / J. Neurosurg. 2005 Jul;103(1):156-64
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2005-07-01 / J. Neurosurg. 2005 Jul;103(1):156-642005-07-01 00:00:002019-02-15 09:00:06Active immunotherapy for advanced intracranial murine tumors by using dendritic cell-tumor cell fusion vaccines
